These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36524397)

  • 21. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.
    Ramassamy C
    Eur J Pharmacol; 2006 Sep; 545(1):51-64. PubMed ID: 16904103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease.
    Carrera I; Cacabelos R
    Curr Neuropharmacol; 2019; 17(3):295-306. PubMed ID: 30479218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases.
    Iyer S; Bhat I; Bangera Sheshappa M
    Mol Nutr Food Res; 2024 Jul; 68(13):e2300409. PubMed ID: 38487969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavonoid-based therapies in the early management of neurodegenerative diseases.
    Solanki I; Parihar P; Mansuri ML; Parihar MS
    Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
    Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
    Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
    CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease.
    Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV
    Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.
    Hor SL; Teoh SL; Lim WL
    Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases.
    Akter R; Rahman H; Behl T; Chowdhury MAR; Manirujjaman M; Bulbul IJ; Elshenaw SE; Tit DM; Bungau S
    CNS Neurol Disord Drug Targets; 2021; 20(5):430-450. PubMed ID: 33602109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wine polyphenols: potential agents in neuroprotection.
    Basli A; Soulet S; Chaher N; Mérillon JM; Chibane M; Monti JP; Richard T
    Oxid Med Cell Longev; 2012; 2012():805762. PubMed ID: 22829964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
    Choi DY; Choi H
    Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.
    Behl T; Makkar R; Sehgal A; Sharma N; Singh S; Albratty M; Najmi A; Meraya AM; Bungau SG
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases.
    Zhang Y; Yu W; Zhang L; Wang M; Chang W
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective Role of Natural Polyphenols.
    Spagnuolo C; Napolitano M; Tedesco I; Moccia S; Milito A; Russo GL
    Curr Top Med Chem; 2016; 16(17):1943-50. PubMed ID: 26845551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.